![Joaquin Mateo: Functional RAD51-IF to detect HRR defects in Prostate Cancer](https://oncodaily.com/pub/uploads/2024/07/Joaquin-Mateo-f-e1738935469674.png)
Joaquin Mateo/axismeded.com
Feb 8, 2025, 06:58
Joaquin Mateo: Functional RAD51-IF to detect HRR defects in Prostate Cancer
Joaquin Mateo, Physician-Scientist at Vall d’Hebron Institute of Oncology, shared an article by Sara Arce-Gallego, et al. on X:
“Our latest paper is out in Cell Reports Medicine – Functional RAD51-IF to detect HRR defects in Prostate Cancer – exploring correlations between HRR mutations, HRD scores, and RAD51-IF in mPC biopsies.”
Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence.
Authors: Sara Arce-Gallego, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 8, 2025, 06:53
Feb 8, 2025, 06:51
Feb 7, 2025, 21:26
Feb 7, 2025, 21:22
Feb 7, 2025, 21:16
Feb 7, 2025, 21:14
Feb 7, 2025, 20:43